InnoCan Pharma Corporation INNO
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -959.00K | -1.51M | -1.12M | -3.23M | -1.58M |
| Total Depreciation and Amortization | 36.00K | 40.00K | 42.00K | 36.00K | 34.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.96M | -1.15M | -675.00K | 2.21M | 972.00K |
| Change in Net Operating Assets | 1.35M | 2.24M | 2.25M | 1.56M | 117.00K |
| Cash from Operations | -1.53M | -379.00K | 495.00K | 572.00K | -453.00K |
| Capital Expenditure | -19.00K | -11.00K | -16.00K | -14.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 0.00 | 1.00K | 69.00K | 69.00K |
| Cash from Investing | -18.00K | -11.00K | -15.00K | 55.00K | 53.00K |
| Total Debt Issued | 650.00K | 450.00K | 640.00K | 640.00K | 640.00K |
| Total Debt Repaid | -3.00K | -7.00K | -11.00K | -17.00K | -20.00K |
| Issuance of Common Stock | 0.00 | 93.00K | 93.00K | 93.00K | 488.00K |
| Repurchase of Common Stock | -- | -- | -- | -123.00K | -123.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 64.00K | 424.00K | 953.00K | 1.42M |
| Cash from Financing | 647.00K | 600.00K | 1.15M | 1.55M | 2.41M |
| Foreign Exchange rate Adjustments | 43.00K | 52.00K | 53.00K | 40.00K | 58.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -856.00K | 262.00K | 1.68M | 2.21M | 2.07M |